Soligenix Inc. (NASDAQ: SNGX)

The QualityStocks Daily Newsletter would like to spotlight Soligenix Inc. (NASDAQ: SNGX).

Soligenix (NASDAQ: SNGX) announced the European Commission has granted orphan drug designation to dusquetide (SGX945) for the treatment of Behçet Disease, following a positive recommendation from the European Medicines Agency and supportive Phase 2a data demonstrating biological efficacy and safety. The designation provides up to 10 years of market exclusivity in the European Union and adds to existing FDA orphan and fast track designations, as the company advances its innate defense regulator platform targeting unmet needs in rare autoimmune conditions.

To view the full press release, visit https://ibn.fm/847sO

Soligenix Inc. (NASDAQ: SNGX) is a late-stage biopharmaceutical company focused on developing and commercializing treatments for rare diseases with high unmet medical needs. Operating through two key segments, the company’s Specialized BioTherapeutics division is dedicated to oncology and inflammation therapies, while its Public Health Solutions segment advances vaccines and therapeutics targeting biothreats and infectious diseases.

The company is actively advancing multiple late-stage clinical programs, including HyBryte™ (SGX301), a novel photodynamic therapy for cutaneous T-cell lymphoma (CTCL). Additional candidates in development target psoriasis (SGX302), oral mucositis (SGX942), and Behçet’s disease (SGX945), while its public health efforts focus on heat-stable vaccines for ricin poisoning (RiVax®), Ebola (SuVax™), and Marburg (MarVax™) viruses, that have been supported by non-dilutive government grants and contracts of approximately $60 million to date.

With a diversified pipeline, multiple orphan and fast-track designations, and collaborations with government agencies, Soligenix is uniquely positioned for potential regulatory approvals and commercialization.

The company is headquartered in Princeton, New Jersey.

Pipeline and Development Programs

Specialized BioTherapeutics

Soligenix’s Specialized BioTherapeutics division develops treatments for oncology and inflammatory diseases, focusing on conditions with few or no effective therapeutic options. HyBryte™ (synthetic hypericin) has completed a Phase 3 study for CTCL, demonstrating statistically significant efficacy, and a second confirmatory Phase 3 trial is actively enrolling patients to support potential regulatory submissions worldwide. If approved, it would be the first non-mutagenic photodynamic therapy for early-stage CTCL, addressing an unmet medical need. It has received orphan drug designations in the U.S. and Europe, as well as Fast Track designation in the U.S.

SGX302, a photodynamic therapy based on the same active ingredient as HyBryte™, is in clinical development for mild-to-moderate psoriasis, with positive Phase 1/2 proof-of-concept results, it is actively enrolling patients in a Phase 2a clinical trial.

SGX942, designed to reduce inflammation and tissue damage in oral mucositis associated with cancer treatment, is progressing as a potential first-in-class therapy.
SGX945, targeting aphthous ulcers in Behçet’s disease, is actively enrolling in a Phase 2a clinical trial and has received fast-track designation, highlighting the urgency of developing effective treatments for this rare inflammatory condition.

Public Health Solutions

The company’s Public Health Solutions segment focuses on medical countermeasures for biothreats and emerging infectious diseases, leveraging non-dilutive government funding to advance its programs. RiVax®, a ricin toxin vaccine, has demonstrated strong preclinical and early clinical results and may be eligible for government procurement under the Strategic National Stockpile initiative.

The company’s RiVax®, as well as its vaccine candidates for Ebola and Marburg viruses are based on its proprietary ThermoVax® technology, which stabilizes vaccines for long-term storage without refrigeration. This approach could be transformative in regions where maintaining cold-chain logistics is challenging.

The ongoing development of these vaccines is supported by funding from NIH, BARDA, and DTRA, with the potential for up to three priority review vouchers (PRVs) upon regulatory approval, to be used for future programs or sold. Notably, PRVs have previously sold for roughly $100 million.

Market Opportunity

Soligenix targets markets with significant commercial potential, focusing on rare diseases and biodefense applications. HyBryte™ addresses CTCL, a disease affecting over 68,000 patients across the U.S. and Europe, with a total market opportunity exceeding $250 million. SGX302, the company’s therapy for mild-to-moderate psoriasis, serves a much larger population, as over eight million people in the U.S. are affected by the condition, representing a global market opportunity exceeding $1 billion.

SGX942, developed for oral mucositis in head and neck cancer patients, is aimed at a market worth more than $500 million, while SGX945 for Behçet’s disease serves a niche segment valued at over $200 million worldwide.

In addition to its rare disease programs, Soligenix’s Public Health Solutions division has the potential to generate significant revenue through government procurement contracts. By focusing on both orphan drug markets and government-funded biodefense initiatives, Soligenix has positioned itself for sustained revenue growth through multiple high-value opportunities.

Leadership Team

Christopher J. Schaber, PhD, Chairman, President & CEO, brings to the company more than 35 years of experience in the biopharmaceutical industry. Before joining Soligenix, he held senior and operational leadership roles at Discovery Laboratories, Acute Therapeutics, Ohmeda Pharmaceuticals, The Liposome Company, and Wyeth Ayerst Laboratories. He has extensive expertise in drug development, regulatory affairs, and corporate strategy, positioning him to drive Soligenix’s growth and advancement toward commercialization.

Richard Straube, MD, Chief Medical Officer, has more than 35 years of experience in drug development and clinical research. Prior to joining Soligenix, he held key leadership roles at Stealth Peptides, INO Therapeutics, Ohmeda Pharmaceuticals, and Centocor. Throughout his career, he has played a crucial role in bringing innovative therapies to market, particularly in inflammatory diseases and immunology, making him a valuable asset in advancing Soligenix’s late-stage clinical programs.

Oreola Donini, PhD, Chief Scientific Officer, has more than 20 years of experience in pharmaceutical research and development, with expertise in immunology, inflammation, and rare diseases. Before joining Soligenix, she held leadership positions at Inimex Pharmaceuticals, ESSA Pharma, and Kinetek Pharmaceuticals, where she worked on novel drug discovery and translational medicine. Her experience in preclinical research and product development supports Soligenix’s continued innovation in biopharmaceuticals.

Jonathan Guarino, CPA, CGMA, Chief Financial Officer, has over 25 years of experience in corporate finance and strategic financial planning. Before joining Soligenix, he held financial leadership positions at Hepion Pharmaceuticals, Covance, BlackRock, and Barnes & Noble. His expertise in financial management, accounting, and capital markets plays a critical role in Soligenix’s financial strategy and operational efficiency.

Soligenix Inc. (NASDAQ: SNGX), closed Thursday's trading session at $1.21, up 0.8333333%, on 4,004,819 volume. The average volume for the last 3 months is 132,478 and the stock's 52-week low/high is $1/$6.2299.

Recent News

• Soligenix Inc. (NASDAQ: SNGX) - BioMedNewsBreaks - Soligenix Inc. (NASDAQ: SNGX) Receives EU Orphan Drug Designation For Dusquetide In Behçet Disease
• Soligenix Inc. (NASDAQ: SNGX) Spotlighted in Recent Zacks Research Report as Key Clinical Milestones Approach
• InvestorNewsBreaks – Soligenix Inc. (NASDAQ: SNGX) Advances Orphan Drug Strategy With HyBryte In Rare Skin Cancer

Powermax Minerals Inc. (CSE: PMAX) (OTCQB: PWMXF)

The QualityStocks Daily Newsletter would like to spotlight Powermax Minerals Inc. (CSE: PMAX) (OTCQB: PWMXF).

This article has been disseminated on behalf of Powermax Minerals Inc. and may include paid advertising.

Powermax Minerals (CSE: PMAX) (OTCQB: PWMXF) (FSE: T23) reported results from integrated geochemical and geophysical analysis at its Atikokan Rare Earth Elements property in Ontario, identifying priority exploration targets within the Dashwa Gneiss Complex supported by rock, soil and sediment anomalies. Results highlight structurally controlled rare earth mineralization associated with thorium and uranium signatures, with TREO values reaching up to 615.8 ppm in soils and 503.3 ppm in rock samples, guiding follow-up exploration as the company advances a model targeting concentrated REE zones along shear corridors and lithological contacts.

To view the full press release, visit https://ibn.fm/xKPpk

Disseminated on behalf of Powermax Minerals Inc., may include paid advertisements.

Powermax Minerals Inc. (CSE: PMAX) (OTCQB: PWMXF) is a Canadian mineral exploration company developing a portfolio of rare earth element (“REE”) projects across Tier-1 jurisdictions in Canada and the United States. Focused on discovery, responsible advancement, and alignment with North America’s critical-minerals strategy, the company targets areas with geological potential for REE-bearing pegmatites and granitic systems.

Its exploration model emphasizes modern geophysics, data integration, and systematic de-risking through technical work. By concentrating on projects with clear infrastructure advantages and policy support, Powermax seeks to contribute meaningfully to regional supply-chain independence in critical minerals vital to electrification and advanced manufacturing.

The company’s growing asset base includes four core REE projects, Atikokan, Cameron, Pinard and Ogden Bear Lodge, positioned within highly prospective geological corridors.

Powermax Minerals is headquartered in Toronto, Ontario.

Projects

Atikokan REE Project – Northwestern Ontario

Powermax’s flagship Atikokan Rare Earth Element Project covers 9,416 hectares across three mineral claim blocks (A, B, and C) approximately 35 kilometers northwest of the town of Atikokan in the Thunder Bay Mining District. Located along the White Otter–Dashwa corridor, the project hosts REE-enriched granitic and pegmatitic systems supported by strong radiometric and geochemical signatures.

In 2025, Powermax completed airborne magnetic and gamma-ray spectrometric surveys, geological mapping, and geochemical sampling. An integrated interpretation released in November 2025 outlined a structural–geochemical corridor of REE enrichment, with Total Rare Earth Element (TREE) values from 254 ppm to 1,947 ppm across Blocks B and C. The company is currently advancing surface validation and target ranking for follow-up work.

Cameron REE Project – British Columbia

The Cameron Project, which the company holds an option to acquire, is located about 30 kilometers south of Revelstoke in the Kamloops Mining Division and comprises three contiguous mineral claims totaling 2,984 hectares.

Hosted within the Monashee Group, the property contains NYF-type granitic pegmatites and gneissic units known to carry both light and heavy REEs. Phase 1 exploration, completed under NI 43-101 recommendations, produced TREE values ranging from 17 ppm to 1,943 ppm, with heavy mineral concentrate samples up to 7,561 ppm. These findings confirmed consistent REE enrichment and led to the launch of Phase 2 exploration in October 2025 to expand mapping and refine drill targets.

Ogden Bear Lodge REE Project – Wyoming, USA

Powermax owns a 100% interest in the Ogden Bear Lodge Project, covering 22 lode claims (184 hectares) in Crook County, Wyoming. The property is prospective for high-grade neodymium-praseodymium (Nd/Pr) oxide mineralization and shares a border with Rare Element Resources’ Bear Lodge Critical Rare Earth Project. That neighboring project has received $24.2 million in U.S. Department of Energy support and a non-binding EXIM Bank letter of interest for up to $553 million in debt financing, highlighting the strategic value of this emerging U.S. REE district.

Pinard Rare Earths Project – Northern Ontario

In November 2025, Powermax Minerals announced plans to acquire a 100% interest in the Pinard Rare Earths Project, located roughly 70 kilometers north-northeast of Kapuskasing, Ontario. The property consists of 255 contiguous claims totaling 5,178 hectares within the Pinard Intrusive Rock Complex, an alkaline igneous system characterized by nepheline syenites and peralkaline granites commonly associated with REE-bearing mineralization.

Market Opportunity

Global demand for rare earth elements is projected to triple—from 59,000 tonnes in 2022 to 176,000 tonnes by 2035—driven by rapid electric-vehicle adoption and wind-power expansion, with supply expected to lag by up to 30%. The global REE market, valued at $3.95 billion in 2024, is forecast to reach $6.3 billion by 2030 at a compound annual growth rate of approximately 8.6%, according to Grand View Research.

China currently controls approximately 60% of REE mining and about 90% of processing capacity, prompting North American governments to accelerate domestic development. In 2025, the U.S. Department of Energy announced $1 billion in critical-minerals funding opportunities, while Canada’s C$1.5 billion Critical Minerals Infrastructure Fund supports projects through 2030. Together, this policy support and structural supply deficit highlight Powermax’s positioning within a strategically essential market tied to the clean-energy transition.

Leadership Team

Paul Gorman, CEO & Director, is a resource-based corporate specialist with more than 25 years of experience in junior mining finance, public listings, and corporate development. He is the President and Managing Partner of Riverbank Capital Inc., where he has raised over $150 million for emerging issuers and helped revitalize the North American graphite industry through the founding of Mega Graphite Inc. Gorman has led multiple exploration programs and was instrumental in achieving high-grade lithium discoveries in 2024 for Pan American Energy Corp.

Michael Malana, Director, has more than 20 years of international experience in financial management, reporting, and corporate governance. He has held senior executive roles across natural resources, biotechnology, and manufacturing and holds a Bachelor of Commerce degree from Concordia University in Montreal. Malana is a Chartered Professional Accountant (Certified Management Accountant).

Afzaal Pirzada, M.Sc., P.Geo., Director, is a professional geoscientist with over 30 years of experience in mineral exploration and mining, specializing in gold, lithium, graphite, rare metals, and uranium. He has served as Project Geologist, VP Exploration, Director, and CEO for multiple mining companies, including Adriana Resources and Rock Tech Lithium. Pirzada is a registered Professional Geoscientist with Engineers and Geoscientists British Columbia and has authored numerous NI 43-101 technical reports.

Powermax Minerals Inc. (OTCQB: PWMXF), closed Thursday's trading session at $0.293, up 2.807%, on 47,497 volume. The average volume for the last 3 months is 104,040 and the stock's 52-week low/high is $0.2402/$1.98.

Recent News

• Powermax Minerals Inc. (CSE: PMAX) (OTCQB: PWMXF) - MiningNewsBreaks - Powermax Minerals Inc. (CSE: PMAX) (OTCQB: PWMXF) (FSE: T23) Identifies Priority REE Targets At Atikokan Property
• Powermax Minerals Inc. (CSE: PMAX) (OTCQB: PWMXF) Identifies Rare Earth Mineralization at Cameron Project, Expands Exploration Targets
• MiningNewsBreaks - Powermax Minerals Inc. (CSE: PMAX) (OTCQB: PWMXF) (FSE: T23) Reports Encouraging Rare Earth Sampling Results at Cameron REE Property

Earth Science Tech Inc. (OTC: ETST)

The QualityStocks Daily Newsletter would like to spotlight Earth Science Tech Inc. (OTC: ETST).

• ETST is focused on compounding pharmacies, telemedicine, and clinical services
• Vertically integrated model supports recurring, patient-driven revenue
• The company’s strategy aligns with increased demand for personalized and digital healthcare

Earth Science Tech (OTC: ETST) is consolidating on its identity as a leading healthcare holding company, implementing a strategy built on vertical integration across telemedicine, pharmaceuticals, and clinical services. The company’s transitioning from legacy operations highlights a distinct alignment with high-growth segments of the healthcare sector, particularly personalized medicine and digital care delivery ( ibn.fm/9lMJg ).

Earth Science Tech Inc. (OTC: ETST) is a strategic holding company that builds value by acquiring and actively managing operating businesses in pharmaceuticals, telemedicine, healthcare services, real estate, and select consumer markets. The company focuses on controlling interests in subsidiaries where operational oversight, regulatory compliance, and disciplined scaling can drive durable growth.

Since 2022, Earth Science Tech has completed a deliberate transition away from legacy activities and repositioned the organization around healthcare and pharmaceutical operations. That shift has been supported by regulatory alignment, expanding operating capabilities, and the assembly of a diversified portfolio of revenue-generating businesses.

Today, the company’s approach emphasizes execution, capital discipline, and long-term value creation across its operating platforms, with a focus on scaling businesses that can grow sustainably while enhancing shareholder value.

The company is headquartered in Miami, Florida.

Subsidiaries

Earth Science Tech conducts its operations through a portfolio of wholly owned and majority-owned subsidiaries spanning pharmaceutical compounding, telemedicine, healthcare services, real estate development, and direct-to-consumer products.

• RxCompoundStore.com LLC – A fully licensed compounding pharmacy based in Miami, Florida, authorized to fulfill prescriptions across more than 20 U.S. states and Puerto Rico, with ongoing licensure expansion efforts nationwide.
• Mister Meds LLC – A Texas-based compounding pharmacy operating from a 5,000-square-foot facility with advanced sterile and hazardous drug compounding capabilities, acquired to expand production capacity and geographic reach.
• Peaks Curative LLC – A telemedicine referral platform providing asynchronous consultations for Peaks-branded compounded medications, supported by an expanding provider network and recent entry into the veterinary market through Zoolzy.com.
• DOConsultations LLC – An online telehealth platform focused on customized medication formulations, supporting direct-to-patient delivery through partner pharmacies.
• Las Villas Health Care Inc. – A brick-and-mortar and telehealth healthcare provider serving the Spanish-speaking community, offering specialized wellness and sexual health services.
• Avenvi LLC – A diversified real estate development and asset management company overseeing property investments, development projects, and the company’s ongoing share repurchase program.
• MagneChef (80% interest) – A direct-to-consumer retail brand leveraging proprietary intellectual property to develop and market kitchen and cooking-related products, with recent expansion into premium American-made BBQ tools.
• Earth Science Foundation Inc. – A 501(c)(3) nonprofit organization serving as the company’s charitable arm, providing financial assistance for prescription costs to qualified individuals.

Collectively, these subsidiaries provide Earth Science Tech with diversified exposure across regulated healthcare services, digital health platforms, real estate assets, and proprietary consumer brands.

Market Opportunity

Earth Science Tech is primarily positioned within the pharmaceutical compounding and telemedicine markets, both of which are experiencing sustained growth driven by demand for personalized healthcare solutions, expanded access to care, and increasing adoption of remote service models.

The pharmaceutical compounding market continues to benefit from rising demand for customized medications, improved patient adherence, and supply-chain flexibility. According to Grand View Research, the global compounding pharmacies market was valued at approximately $13.1 billion in 2023 and is projected to reach $18.6 billion by 2030, representing a compound annual growth rate of 5.11% from 2024 to 2030. Earth Science Tech’s compounding operations through RxCompoundStore.com and Mister Meds align directly with this expanding market segment.

Telemedicine represents a second core growth vertical for the company, supporting the clinical delivery of pharmaceutical products and healthcare services. According to Fortune Business Insights, the global telemedicine market was valued at $111.99 billion in 2025 and is projected to grow to $532.08 billion by 2034, reflecting a compound annual growth rate of 20.0%, with North America accounting for approximately 48% of market share in 2025. Platforms operated by Peaks Curative and DOConsultations participate directly in this rapidly expanding digital health ecosystem.

Additional exposure to specialty healthcare clinics and real estate development provides diversification alongside the company’s core pharmaceutical and telemedicine operations.

Leadership Team

Giorgio R. Saumat, Chief Executive Officer and Chairman of the Board, is an investor and entrepreneur with more than 20 years of experience investing in, operating, and advising private businesses, including founding CASAU Group, a private equity firm focused on real estate, and POINT96 Consulting, which provides strategic planning services to businesses and accredited investors.

Ernesto L. Flores, Chief Financial Officer, is a financial executive with over a decade of experience in accounting, taxation, and financial management, having held senior roles overseeing compliance and financial operations at logistics and investment firms.

Mario G. Tabraue, President and Chief Operating Officer, brings experience across real estate, maritime operations, and digital infrastructure and was instrumental in acquiring RxCompoundStore.com with the vision of scaling it into a nationally competitive pharmaceutical and telemedicine platform.

Christopher Rose, Chief Technology Officer, is a technology and automation executive who previously led enterprise-wide automation initiatives at a Fortune 100 company, delivering large-scale operational efficiencies and global process automation.

Earth Science Tech Inc. (OTC: ETST), closed Thursday's trading session at $0.0946, up 11.9527%, on 182,722 volume. The average volume for the last 3 months is 52,000 and the stock's 52-week low/high is $0.001/$0.237.

Recent News

• Earth Science Tech Inc. (OTC: ETST) - Earth Science Tech Inc. (ETST) Builds Integrated Healthcare Platform for Scalable Growth
• BioMedNewsBreaks - Earth Science Tech, Inc. (OTC: ETST) Launches MyOnlineConsultation Platform Through MOCTeledoc
• Earth Science Tech Inc. (ETST) Builds Telehealth, Pharmacy Links in Evolving Digital Care

GlobalTech Corp. (OTC: GLTK)

The QualityStocks Daily Newsletter would like to spotlight GlobalTech Corp. (OTC: GLTK).

GlobalTech (OTC: GLTK) announced its common stock has been approved for quotation on the OTCQB Venture Market, marking a key milestone in its capital markets strategy as it advances from the OTCID tier. The uplisting reflects the company’s progress in corporate governance and SEC reporting compliance while enhancing investor access, visibility and liquidity, as GlobalTech continues positioning itself for a potential future listing on the Nasdaq Capital Market.

To view the full press release, visit https://ibn.fm/TvF6M

GlobalTech Corp. (OTC: GLTK) is a U.S.-based technology holding company specializing in artificial intelligence (AI), big data, and digital infrastructure. Advancing toward a Nasdaq listing, the company balances internal innovation with strategic acquisitions to accelerate growth and long-term value creation.

GlobalTech’s diversified portfolio spans AI-powered solutions for enterprise productivity, e-commerce, retail, digital lending, compliance, and other high-growth domains. Flagship platforms include ThrivoAI, Cadnz, Baseball Blitz, Talina, ProtoEd, BillCare, Giftio, and EntityScan. The company also holds a majority stake in WorldCall Telecom Ltd., extending its telecommunications presence in Pakistan and supporting infrastructure-led value creation.

To strengthen market reach, GlobalTech continues to evaluate technology-centric acquisitions while also expanding through strategic regional alliances. Its partnership with significant regional players like Omantel anchors growth in the Middle East, a key gateway market. At the same time, the company’s Center of Excellence (CoE) and #GTCTalks knowledge platform position it as a thought leader in emerging technologies.

Supported by a seasoned leadership team and a disciplined execution model, GlobalTech is building sustainable momentum across global AI and big data markets, with the governance, innovation, and agility required to capture outsized opportunities in the digital economy.

GlobalTech Corp. (OTC: GLTK), closed Thursday's trading session at $1.31, even for the day. The average volume for the last 3 months is and the stock's 52-week low/high is $1.1/$3.4.

Recent News

• GlobalTech Corp. (OTC: GLTK) - InvestorNewsBreaks - GlobalTech Corp. (OTC: GLTK) Approved For OTCQB Venture Market Listing
• Anthropic Claims Chinese AI Companies are "Distilling" Claude
• Dutch Air Force Tests AI Simulators That React to Pilots' Brain Activity

Pelican Acquisition Corp. (NASDAQ: PELI)

The QualityStocks Daily Newsletter would like to spotlight Pelican Acquisition Corp. (NASDAQ: PELI).

Pelican Acquisition (NASDAQ: PELI) announced the successful completion of its business combination with Pelican Holdco Inc., Greenland Exploration Limited and March GL Company, forming Greenland Energy Company, which will begin trading on The Nasdaq Stock Market under the ticker (NASDAQ: GLND) on March 26, 2026. The combined company is advancing development of the Jameson Land Basin in East Greenland, where reprocessed seismic data has identified more than 50 oil and gas targets and independent estimates suggest up to 13 billion barrels of recoverable oil, as it prepares for initial drilling supported by established infrastructure, logistics partnerships and key service providers.

To view the full press release, visit https://ibn.fm/GhN28

Pelican Acquisition Corp. (NASDAQ: PELI) is a publicly traded special purpose acquisition company formed for the purpose of effecting a merger, share exchange, asset acquisition, share purchase, reorganization or similar business combination with one or more businesses.

Pelican has entered into a proposed business combination with Greenland Exploration Limited and March GL Company that is expected to close on March 17, 2026, and result in the creation of Greenland Energy Company, a publicly traded entity focused on the development of energy resources in Greenland’s Jameson Land Basin.

On February 24, 2026, Pelican announced that the U.S. Securities and Exchange Commission had declared effective the company’s registration statement on Form S-4 in connection with the proposed transaction, and Pelican scheduled a shareholder meeting to vote on the business combination.

Greenland Energy Company

Greenland Energy Company is expected to be formed through the business combination of Pelican Acquisition Corp., Greenland Exploration Limited and March GL Company to pursue oil and gas exploration in Greenland’s Jameson Land Basin, one of the last highly prospective yet largely undrilled basins globally, with a scale comparable to many of the world’s major producing regions.

Greenland Exploration Limited

Greenland Exploration Limited is a Texas-based entity focused on developing strategic positions in North American energy assets. Through its partnerships and future acquisitions, the company seeks to deliver long-term shareholder value in a dynamic and evolving energy market.

March GL Company

March GL Company is a privately owned Texas corporation that entered into an agreement with 80 Mile to begin drilling in the Jameson oil and gas basin in Greenland. The company will fund 100% of the costs associated with up to two exploration wells designed to delineate the sedimentary structure and energy potential of the basin.

Through its agreement with 80 Mile and its subsidiary White Flame Energy A/S, March GL may earn up to a 70% interest in three onshore licenses covering more than 2 million acres across the Jameson Land Basin. March GL will also serve as Field Operations Manager for the project.

Market Opportunity

According to the U.S. Energy Information Administration, the Arctic holds an estimated 13% of the world’s undiscovered conventional oil resources, or approximately 90 billion barrels, and 30% of its undiscovered conventional natural gas resources. The commercial development of these resources has historically been limited by the difficulty and cost associated with operating in Arctic environments.

The Jameson Land Basin on Greenland’s east coast represents one of the Arctic regions where exploration has historically been limited despite significant geological interest. Historic exploration campaigns conducted by Atlantic Richfield in the 1980s collected approximately 1,800 kilometers of seismic data and identified geological structures capable of trapping large volumes of hydrocarbons.

Greenland Energy’s exploration team has reprocessed this seismic data using modern imaging technology and identified more than 50 potential oil and gas targets within the basin. Early geological models suggest the basin could contain more than 13 billion barrels of recoverable oil if exploration results confirm the resource potential.

Leadership Team

Robert Price, Chief Executive Officer of March GL Company and incoming Chief Executive Officer of Greenland Energy Company, has assembled and managed companies across the energy, real estate and manufacturing sectors. He founded Brooks Energy Company in 1991 and previously served as Vice President, Trust Officer and Oil and Gas Trust Energy Department Manager at the First National Bank and Trust Company of Tulsa, now J.P. Morgan Chase Bank. At March GL, he oversaw the reprocessing of approximately 1,800 kilometers of historic seismic data from Greenland’s Jameson Land Basin.

Larry G. Swets Jr., Chief Executive Officer of Greenland Exploration Limited and incoming Executive Chairman of Greenland Energy Company, has been involved in advancing the development of energy resources in Greenland’s Jameson Land Basin through Greenland Exploration’s planned merger with March GL Company and Pelican Acquisition Corp.

Pelican Acquisition Corp. (NASDAQ: PELI), closed Thursday's trading session at $8.23, even for the day. The average volume for the last 3 months is 221,338 and the stock's 52-week low/high is $7.52/$12.48.

Recent News

• Pelican Acquisition Corp. (NASDAQ: PELI) - InvestorNewsBreaks - Pelican Acquisition Corp. (NASDAQ: PELI) Completes Business Combination, Greenland Energy Company To Trade As (NASDAQ: GLND)
• Pelican Acquisition Corp. (NASDAQ: PELI) Is 'One to Watch'
• NetworkNewsBreaks - Pelican Acquisition Corp. (NASDAQ: PELI) Announces Arctic Logistics Agreement Supporting Greenland Energy Drilling Campaign

D-Wave Quantum Inc. (NYSE: QBTS)

The QualityStocks Daily Newsletter would like to spotlight D-Wave Quantum Inc. (NYSE: QBTS).

D-Wave Quantum Inc. (NYSE: QBTS) (“D-Wave” or the “Company”), the only dual-platform quantum computing company providing both annealing and gate-model systems, software and services, recently announced that it will launch a new podcast series, “Quantum Matters,” on April 7, 2026. Reinforcing D-Wave’s unique position as the world’s first commercial quantum computing company, the podcast will feature conversations with industry leaders, researchers, academics and scientists on how quantum computing is applied across business and science today, and where the technology is headed . Hosted by Murray Thom, D-Wave vice president of quantum technology evangelism, the podcast will examine how organizations are currently using quantum computing to solve computationally complex problems in areas such as manufacturing, supply chain, aerospace, life sciences and artificial intelligence. “D-Wave’s quantum computing technology has moved beyond theory and into real-world deployment,” said Murray Thom. “With this podcast, we’re convening and elevating the voices of the first-movers who are boldly exploring and deploying this groundbreaking technology to achieve operational excellence, drive business impact and fuel scientific breakthroughs.”

To view the full press release, visit https://ibn.fm/Mw2sU

D-Wave Quantum Inc. (NYSE: QBTS) is a leader in quantum computing systems, software and services focused on delivering customer value via practical quantum applications for problems such as logistics, artificial intelligence, materials sciences, drug discovery, scheduling, fault detection and financial modeling. As the only provider building both annealing and gate-model quantum computers, the company is unlocking commercial use cases in optimization today, while building the technologies that will enable new solutions tomorrow.

D-Wave is a pioneer in quantum computing, with a history of delivering the world’s first commercial quantum computer; the first real-time quantum cloud service; countless hardware and software product and research milestones; and the planned first cross-platform quantum solution which will deliver both annealing and gate-model quantum computers to customers via an integrated platform. Its current commercial product offerings include: Advantage™ (fifth generation quantum computer), Leap™ (quantum cloud service), Launch™ (quantum computing onboarding service) and Ocean™ (full suite of open-source programming tools).

D-Wave’s relentless pursuit of practical quantum computing has resulted in the technology being used today by some of the world’s most advanced enterprises – more than 25 of the Forbes Global 2000 use D-Wave.

D-Wave’s commercial customers include blue-chip industry leaders like Volkswagen, Accenture, BBVA, NEC Corporation, Save-On-Foods, DENSO and Lockheed Martin. The company boasts an extensive IP portfolio featuring more than 200 issued U.S. patents and over 100 peer-reviewed papers published in leading scientific journals.

Founded in 1999, D-Wave is the world’s first commercial supplier of quantum computers. With headquarters and the Quantum Engineering Center of Excellence based near Vancouver, Canada, D-Wave’s U.S. operations are based in Palo Alto, California.

Advantage™ Quantum Computer

 

With the Advantage™ Quantum Computer, D-Wave has incorporated two decades of experience and over 10 years of customer feedback to create the first and only quantum computer designed for business. The platform features a new processor architecture with over 5,000 qubits and 15-way qubit connectivity. This is 2.5x more connections and more than double the number of qubits than the company’s previous generation quantum computer.

D-Wave’s quantum computers, first located in its facilities in British Columbia, have been available to North American users through its Leap™ quantum cloud service since 2018. It has since introduced new Advantage systems in Julich, Germany, and most recently, Marina Del Rey, California, which marked the availability of the first Advantage quantum computer physically located in the United States.

That new deployment is part of the USC-Lockheed Martin Quantum Computing Center (QCC) hosted at USC’s Information Sciences Institute (ISI), a unit of the University of Southern California’s prestigious Viterbi School of Engineering. Additionally, Amazon Web Services (AWS) and D-Wave announced that the U.S.-based system is available for use in Amazon 2racket, expanding the number to three different D-Wave quantum systems available to AWS users.

Leap Quantum Cloud Service

 

D-Wave’s customers interface with its systems through the Leap™ quantum cloud service. Leap delivers immediate, real-time access to the company’s Advantage quantum computer and quantum hybrid solver service, all with enterprise-class performance and scalability.

Leap allows developers proficient in Python to get started building and running quantum applications. Through a seamless and secure cloud-based connection, users can easily start solving complex problems of up to 1 million variables and 100,000 constraints.

Using Leap, D-Wave customers have developed quantum hybrid applications for use cases in manufacturing, logistics, financial services, life sciences, materials science, retail and transportation. By eliminating the need to wait hours, days or weeks to get good answers to a broad array of problems, D-Wave is helping businesses move forward.

D-Wave Launch

D-Wave Launch™ is the company’s onboarding platform aimed at helping businesses easily start their quantum journey. Through this program, D-Wave’s team of experts and partners aid enterprises in identifying best use cases for quantum and work with them to develop a proof of concept and production pilot.

From there, the team coordinates with customers to get their hybrid quantum applications up and running, providing ongoing Leap quantum cloud access to ensure the application is operating smoothly and delivering real business value.

Target Verticals

While the potential applications for quantum computing are effectively limitless, D-Wave has identified a number of industry verticals as key areas of focus for its quantum architecture, providing case studies for each. These include:

• Manufacturing – D-Wave worked with Volkswagen to identify a commercial optimization application, the binary paint shop problem, which was run on D-Wave’s hybrid solver service. The solver outperformed four purely classical methods on problem sizes at commercial scale (N=3,000). In a separate project, similar inputs were tested using a leading ion trap system, which failed to find any commercial solution.
• Life Sciences – Menten AI makes use of D-Wave quantum computing to assist in the design of novel therapeutic peptides—short strings of amino acids that can act as potent drugs. With the rise of COVID-19, D-Wave’s Advantage system made it possible to identify molecules that might be especially well-suited for binding and inhibiting the related spike protein, producing several promising peptide designs.
• Finance – Multiverse Computing, a leader in developing quantum solutions for the financial sector, leveraged D-Wave’s hybrid solver service in a collaboration with BBVA, one of the world’s largest financial institutions. Multiverse demonstrated management strategies that far exceeded the granularity of traditional returns in a fraction of the time, helping BBVA identify a low-risk portfolio for investment.

Market Opportunity

The quantum computing total addressable market is projected to grow between $450 billion and $850 billion over the next 15 to 30 years, with between $5 billion and $10 billion of anticipated TAM growth coming in the next three to five years, according to Boston Consulting Group. Driving factors behind this growth include rising investments in quantum computing tech by governments and an increasing number of commercial use-cases.

Forward-thinking organizations see quantum as an opportunity to move ahead of the competition. From finding efficiencies and reducing waste to decreasing time to solution and solving problems abandoned due to complexity, the business value is real. According to data from 451 Research, 40% of large enterprises are already experimenting with quantum computing.

D-Wave is strategically positioned – in an industry with significant barriers to entry – as evident by a decades-long track record serving a roster of blue-chip customers. The company is singularly focused on helping its customers achieve clear value by leveraging quantum computing in practical business applications. With a full stack of systems, software, developer tools and services, D-Wave is working to enable enterprises, governments, developers and researchers to access the power of quantum computing, thereby providing an intriguing opportunity for prospective investors.

D-Wave’s current investor base includes PSP Investments, Goldman Sachs, BDC Capital, NEC Corporation, Aegis Group Partners and In-Q-Tel.

Leadership Team

Dr. Alan Baratz has served as the CEO of D-Wave since 2020. Previously, as Executive Vice President of R&D and Chief Product Officer, he drove the development, delivery, and support of all of D-Wave’s products, technologies, and applications. Dr. Baratz has over 25 years of experience in product development and bringing new products to market at leading technology companies and software startups. As the first president of JavaSoft at Sun Microsystems, he oversaw the growth and adoption of the Java platform from its infancy to a robust platform supporting mission-critical applications in nearly 80 percent of Fortune 1000 companies. He has also held executive positions at Symphony, Avaya, Cisco, and IBM. Dr. Baratz holds a doctorate in computer science from the Massachusetts Institute of Technology.

John Markovich is the company’s CFO. He brings to D-Wave over three decades of experience working with rapidly growing private and public technology companies across all stages of development. Mr. Markovich has directed the finance, accounting, tax, treasury, M&A, legal, operations, customer service, IR, HR, and IT functions for companies ranging from privately held pre-revenue startups to an NYSE-listed Fortune 500 multi-national company with over $1.2 billion in annual revenue. During his career, he has negotiated and closed over 150 debt, equity, M&A, and joint venture transactions exceeding $2.5 billion in value; over a dozen private placements; nearly a dozen M&A transactions; and several international joint ventures. Mr. Markovich holds a BS in Business from Miami University and an MBA from the Michigan State Graduate School of Business.

D-Wave Quantum Inc. (NYSE: QBTS), closed Thursday's trading session at $14.65, off by 9.512%, on 20,256,315 volume. The average volume for the last 3 months is 23,133,270 and the stock's 52-week low/high is $5.77/$46.75.

Recent News

• D-Wave Quantum Inc. (NYSE: QBTS) - BillionDollarBreaks - D-Wave Quantum Inc. (NYSE: QBTS) to Premiere "Quantum Matters" Podcast
• Political Campaigns Start Featuring Ads Created Using AI
• MissionIRNewsBreaks - Rail Vision Ltd. (NASDAQ: RVSN) Begins Trading On Frankfurt Stock Exchange

Safe Pro Group Inc. (NASDAQ: SPAI)

The QualityStocks Daily Newsletter would like to spotlight Safe Pro Group Inc. (NASDAQ: SPAI).

Safe Pro Group (NASDAQ: SPAI) , according to reporting by Military AI, demonstrated its AI-powered drone decision-support system during a U.S. Army Transforming in Contact 2.0 exercise at Fort Hood, where soldiers used the technology to convert drone imagery into real-time battlefield intelligence. The system identified threats such as landmines and unexploded ordnance, generated 2D and 3D terrain maps for mission planning and operated at the edge without constant connectivity, highlighting its potential to enhance situational awareness and significantly reduce risk in high-stakes operations like breaching.

To view the full article, visit https://ibn.fm/KKhQT

Safe Pro Group Inc. (NASDAQ: SPAI) is a mission-driven technology company delivering advanced AI-powered security and defense solutions. It is focused on serving customers in the defense, homeland security, humanitarian, law enforcement, and commercial markets where its AI, drone-based services and ballistic protective gear can synergistically deliver safety and operational efficiency.

At the heart of Safe Pro’s mission is its patented artificial intelligence (AI), machine learning (ML), deep learning and applied computer vision software technology. These tools are currently being used to rapidly detect small objects in drone-based video and imagery such as landmines and unexploded ordnance (UXO), enabling safer and more efficient field operations across global conflict and post-conflict zones and supporting efforts to improve the reliability of critical infrastructure. The company’s vision is to lead the evolution of security and threat detection through AI innovation, while its mission is to empower governments, enterprises, and humanitarian organizations with tools to respond to evolving threats at scale.

With a team of leaders and subject matter experts drawn from the defense, technology, and public safety sectors, Safe Pro Group delivers U.S.-developed next-generation AI and drone services through its Safe Pro AI and Airborne Response units and high-performance, American-made ballistic protective solutions through its Safe-Pro USA subsidiary.

The company is headquartered in Aventura, Florida.

Products

Safe Pro Group’s three business units operate across software, hardware, and field services to deliver a comprehensive suite of solutions. Each division plays a distinct role in supporting defense, humanitarian and public safety missions around the world.

Safe Pro AI

Safe Pro AI’s core AI-powered computer vision technology enables the rapid analysis of drone-based imagery to autonomously detect objects of interest. Its flagship product, SpotlightAI™ can detect and label over 150 types of explosive threats including landmines, cluster munitions, and unexploded ordnance (UXO). Built on more than two years of real-world usage in Ukraine and now including additional imagery being gathered from the Asian-Pacific region and Africa, SpotlightAI™ rapidly processes and creates high-resolution maps supported by the hyper scalability of the Amazon Web Services (AWS) cloud or detects threats in real-time locally through its OnSite Windows-based software application. Today, the platform boasts one of the world’s largest datasets built on over 1.6 million real-world battlefield images from Ukraine, identifying 28,000+ threats across more than 6,750 hectares, an area equivalent in size to Manhattan.

Airborne Response

Airborne Response is a leading provider of mission critical drone services using U.S. Government-compliant small uncrewed aircraft systems (sUAS) (drones). It serves enterprises in utilities & telecom and insurance with a full-range of drone-based critical infrastructure inspection and monitoring solutions as well as Drone-as-a-First Responder (DFR) services for law enforcement and public safety. It provides customers with actionable intelligence though data capture, analytics and processing powered by AI.

Safe-Pro USA

Safe-Pro USA manufactures ultra-premium, American-made ballistic protection systems including advanced body armor and ballistic plates as well as complete Explosive Ordnance Disposal (EOD) suits, demining aprons, and bomb blankets. All products exceed U.S. and NATO standards and are designed, engineered, and produced in the U.S., supporting customers across military, humanitarian, and law enforcement sectors.

Market Opportunity

Harnessing its patented, real-time, AI-powered processing of drone-based imagery, Safe Pro is creating a uniquely powerful ‘Next-Gen’ approach to situational awareness supporting ground-based personnel in safely completing their defense/military, humanitarian, law enforcement & commercial missions.

The global threat posed by landmines and UXO spans nearly 60 countries, affecting millions of civilians and imposing significant economic burdens, particularly in agriculture and infrastructure. In Ukraine alone, the contamination of 17 million hectares has resulted in $50+ billion in agricultural losses, with World Bank estimates projecting $30 billion needed in demining costs. According to the Landmine Monitor 2024, regions in Asia, Africa, and Latin America continue to report high casualty rates.

Safe Pro is positioned to capture a portion of the $15 billion+ global defense tech market, especially in AI-driven battlefield intelligence, drone surveillance, and threat detection. As a U.S.-based AI and defense technology provider with a HUBZone-certified manufacturing arm, Safe Pro is eligible for federal and state procurement programs, public safety grants, and critical infrastructure contracts, as well as global humanitarian demining efforts.

Leadership Team

Dan Erdberg, Chairman and CEO, brings over 20 years of experience as a C-level technology executive. He has led multiple Nasdaq listings in the drone, 5G, and satellite communications sectors, raised over $50 million in growth capital, and spearheaded Safe Pro Group’s corporate strategy and acquisitions.

Theresa Carlise, Chief Financial Officer, has more than 30 years of experience in financial leadership roles for public companies. Her expertise includes equity transactions, strategic planning, and financial restructuring. She served as Chief Financial Officer, Secretary, Treasurer and Director of various publicly traded companies within the retail, telecommunications, distribution, transportation, mortgage banking and construction sectors.

Pravin Borkar, CTO and Director (President, Safe-Pro USA), has over 30 years of experience in the engineering and manufacturing of ballistic protection systems for the U.S. Department of Defense. He has developed armor solutions for personnel and aircraft platforms including the CH-53 and Blackhawk.

Christopher Todd, President (Airborne Response), is a drone industry veteran and Certified Emergency Manager (CEM®) with more than 30 years of experience. He founded Airborne Response and is President of AUVSI Florida, with expertise in public safety drone deployment and emergency response.

Safe Pro Group Inc. (NASDAQ: SPAI), closed Thursday's trading session at $4.04, off by 7.3394%, on 144,440 volume. The average volume for the last 3 months is 538,887 and the stock's 52-week low/high is $1.47/$9.1599.

Recent News

• Safe Pro Group Inc. (NASDAQ: SPAI) - DefenseNewsBreaks - Safe Pro Group Inc. (NASDAQ: SPAI) Demonstrates AI Drone Decision Support In U.S. Army Exercise
• DefenseNewsBreaks - Safe Pro Group Inc. (NASDAQ: SPAI) Appoints Defense Acquisition Expert Brian Mack to Strategic Advisory Board
• Safe Pro Group Inc. (NASDAQ: SPAI) Successfully Uses the Company’s AI Tools in Real-World Operational Environments at Recent U.S. Army Event

LIXTE Biotechnology Holdings Inc. (NASDAQ: LIXT)

Disseminated on behalf of Nevada Organic Phosphate Inc., may include paid advertisements.

The QualityStocks Daily Newsletter would like to spotlight LIXTE Biotechnology Holdings Inc. (NASDAQ: LIXT).

• LIXT is developing LB-100, a first-in-class therapy designed to enhance the effectiveness of established cancer treatments while cutting down toxicity
• Strategic partnership with Liora Technologies integrates multimodal oncology data, enabling precision-guided patient care and streamlined clinical trials
• These developments position the company at the intersection of innovation and therapeutics

Lixte Biotech Holdings (NASDAQ: LIXT) is advancing the frontiers of precision oncology, developing therapies that complement existing cancer treatments while integrating cutting-edge data solutions. The company’s lead program, LB-100, is a novel small-molecule compound designed to enhance the efficacy of chemotherapy and radiation, aiming to improve patient outcomes while reducing treatment-related side effects. By focusing on improving the therapeutic index of existing cancer modalities, the company is tackling a recurrent challenge in the field of oncology: maximizing treatment impact while cutting down risks to healthy tissue.

LIXTE Biotechnology Holdings Inc. (NASDAQ: LIXT) is a clinical-stage pharmaceutical company developing differentiated cancer therapies built around a novel biological target. Rather than introducing standalone treatments, the company is focused on advancing a first-in-class approach designed to enhance the effectiveness of established cancer therapies, addressing persistent challenges that continue to limit outcomes in oncology.

LIXTE’s work centers on improving how chemotherapy and immunotherapy perform in difficult-to-treat cancers with significant unmet medical need. By translating a distinct scientific concept into therapies that can be integrated into existing treatment frameworks, the company aims to expand the reach and impact of current standards of care without requiring wholesale changes to clinical practice.

Alongside internal development, LIXTE has pursued selective strategic actions that extend its capabilities beyond drug development, supporting its evolution into a platform-oriented oncology company spanning both pharmaceutical and technology-driven approaches.

The company is headquartered in Boca Raton, Florida.

Portfolio

LB-100 (PP2A Inhibitor Platform)

LIXTE’s lead clinical candidate, LB-100, is a proprietary small-molecule inhibitor of protein phosphatase 2A (PP2A) designed to enhance the activity of chemotherapy and immunotherapy. The compound has demonstrated a favorable safety profile in Phase 1 clinical trials and has been supported by more than 25 published preclinical and translational studies. LB-100 is currently being evaluated in multiple clinical programs targeting solid tumors with limited treatment options.

Ongoing trials include combinations of LB-100 with immunotherapy in ovarian clear cell carcinoma and metastatic MSI-low colon cancer, as well as combination therapy with chemotherapy in advanced soft tissue sarcoma. These studies are being conducted in collaboration with leading academic cancer centers and industry partners, reflecting LIXTE’s emphasis on externally validated clinical execution.

Radiotherapy Platform Expansion (Liora Technologies)

In November 2025, LIXTE expanded beyond pharmaceuticals with the acquisition of Liora Technologies Europe Ltd., adding an electronically controlled proton therapy platform known as the LiGHT System. This acquisition established LIXTE’s entry into radiotherapy, complementing its drug development activities and creating optionality for future recurring revenue models tied to jointly operated treatment centers.

Market Opportunity

LIXTE is targeting cancers where existing therapies show limited durability due to resistance, toxicity constraints, or suboptimal patient response. Chemotherapy and immunotherapy are widely applicable across tumor types but remain constrained by these factors, creating an opportunity for approaches that improve efficacy without proportionally increasing toxicity.

The company’s clinical programs focus on ovarian clear cell carcinoma, metastatic colon cancer, and advanced soft tissue sarcoma, indications characterized by high unmet need and limited effective treatment options. Rather than reshaping oncology care, LIXTE is developing LB-100 to augment existing therapies, an approach that could support wider clinical use within established treatment pathways.

Leadership Team

Geordan Pursglove, Chairman, President and Chief Executive Officer, is an accomplished executive and entrepreneur with more than a decade of experience spanning mergers and acquisitions, capital markets, strategic growth initiatives, and operational leadership across both public and private companies. His background includes leadership roles across technology, logistics, customer experience, sports, and marketing, with a focus on scaling organizations, raising capital, and executing transformative strategies.

Bas van der Baan, Chief Scientific Officer, has more than 20 years of experience in biotechnology with a concentration in oncology and diagnostics. He previously served as Chief Clinical and Business Development Officer at Agendia, where he played a key role in initiating and executing clinical trials that supported the commercialization of precision molecular oncology diagnostics in both the U.S. and Europe.

Peter Stazzone, Chief Financial Officer, brings over two decades of financial management experience across publicly traded and privately held companies. His background includes leading capital raises, mergers and acquisitions, financial controls, and public company reporting, with prior CFO roles at companies including Beyond Commerce, Strainz, and Voice Telecom.

LIXTE Biotechnology Holdings Inc. (NASDAQ: LIXT), closed Thursday's trading session at $2.965, off by 0.8361204%, on 76,364 volume. The average volume for the last 3 months is 34,841 and the stock's 52-week low/high is $0.64/$6.26.

Recent News

• LIXTE Biotechnology Holdings Inc. (NASDAQ: LIXT) - Lixte Biotech Holdings Inc. (NASDAQ: LIXT) Advances Precision Oncology with LB-100, Strengthens Position Through Liora Technologies Partnership
• Landmark Proton Therapy Data Changes the Conversation; LIXTE Saw It Coming
• LIXTE Biotechnology Holdings Inc. (NASDAQ: LIXT) Advances PP2A Inhibition Strategy in Evolving Oncology Landscape

SPARC AI Inc. (CSE: SPAI) (OTCQB: SPAIF)

The QualityStocks Daily Newsletter would like to spotlight SPARC AI Inc. (CSE: SPAI) (OTCQB: SPAIF).

This article has been disseminated on behalf of SPARC AI Inc. and may include paid advertising.

• While it might not be getting as much attention as other aspects of the current conflicts in Ukraine and the Middle East, GPS jamming is playing a silent, but important role in modern warfare.
• GPS jamming is a warfare tactic that involves using radio frequency noise to overwhelm lower-power signals to disrupt communication, drone navigation, and guided munitions.
• To help combat GPS jamming, SPARC AI has developed next-gen GPS-free target acquisition system and autonomous navigation software for drones and edge devices, to let them fly without relying on GPS.

While issues like drone attacks and heavy artillery strikes steal many of the headlines about the recent conflicts in the Middle East and Ukraine, there’s a hidden battle being fought behind the scenes. This hidden aspect plays a much bigger part of modern conflicts than you might think. GPS jamming is a tactic where high-powered radio signals are used to block and overwhelm lower-power signals. The purpose of this is to emit enough noise on the same frequency that it disrupts legitimate signals from GPS satellites, often leading to a loss of tracking, navigation failure, and other errors. It may be used offensively to disorient enemy ship navigation and disrupt communication efforts, but also defensively to form an “invisible shield” around an area of importance, denying precision strikes and/or drones that often rely on GPS to reach their target. Many aspects of war today rely on communication and tracking via GPS or similar signals, and jamming can cause severe disruptions within these systems, leading to mass confusion, inaccurate navigation, accidents, and much less situational awareness for ground teams. However, with how prevalent GPS jamming is becoming, and how disruptive it can be during a conflict, some are creating solutions to combat GPS jamming. For example, SPARC AI (CSE: SPAI) (OTCQB: SPAIF) develops GPS-free target acquisition system and autonomous navigation software for drones and edge devices.

SPARC AI (CSE: SPAI) (OTCQB: SPAIF) (Frankfurt: 5OV0) announced the appointment of an in-country referral agent in Ukraine to expand commercial engagement with defense stakeholders and support deployment of its Overwatch GPS-denied navigation and target acquisition platform. The agent will leverage established relationships with Ukrainian defense personnel to facilitate introductions and accelerate potential commercial agreements, as SPARC AI builds on ongoing drone testing and positions its AI-enabled capabilities within one of the world’s most demanding electronic warfare environments.

To view the full press release, visit https://ibn.fm/bR6Ll

SPARC AI Inc. (CSE: SPAI) (OTCQB: SPAIF) develops next-generation, GPS-free target acquisition system and autonomous navigation software for drones and edge devices. Its zero-signature technology delivers real-time detection, tracking, and behavioral insights without reliance on radar, lidar, or heavy sensors. The company’s platform transforms unmanned systems into autonomous tools capable of identifying and engaging targets in GPS-denied environments.

The company’s vision is to redefine situational awareness by merging advanced mathematics, AI modeling, and edge computing into a unified intelligence architecture. SPARC AI aims to empower defense, rescue, and commercial organizations to operate safely and effectively in signal-contested environments where traditional navigation systems fail.

Its mission is to build the world’s most trusted geolocation intelligence platform that operates without GPS, enabling seamless interoperability across air, land, and sea devices.

SPARC AI is headquartered in Toronto, Canada.

Technology

SPARC AI’s technology suite delivers precision target acquisition, navigation, and autonomous intelligence in environments where GPS and traditional sensors fail. At its core is the Target Acquisition System, a software-only solution that determines the geolocation of any visible object using camera telemetry data. By removing the need for specialized hardware like lasers, radar, or lidar, the platform reduces weight, power use, and cost. Built on advanced mathematical modeling, it constructs a 3D understanding of terrain and position, achieving GPS-level accuracy in a zero-signature configuration suited for defense, rescue, and commercial operations.

SPARC AI Mobile extends this capability to handheld and field-issued devices, allowing operators to mark and transmit target coordinates directly from smartphones or rugged tablets. Once a target is identified, the device relays the coordinates to a connected drone, which autonomously navigates to the location for reconnaissance or engagement. The mobile system maintains accuracy even in GPS-jammed or degraded environments, turning each device into a connected node within a broader distributed network.

The company’s GPS-Denied Navigation engine enables mission planning and execution without satellite signals. Operators can design flight paths, define perimeters, and simulate routes to identify optimal vantage points and minimize resource use. Counter-surveillance and threat-prediction tools model adversarial visibility, helping users avoid detection and maximize ground coverage. Together, these capabilities form the foundation of SPARC AI’s software architecture, providing the intelligence backbone for its integrated command platform.

Overwatch Target Intelligence

Overwatch unifies all SPARC AI technologies, including its Target Acquisition, Mobile, and Navigation systems, into a single mission-ready platform that fuses detection, classification, tracking, and navigation in real time. It transforms drones and robotic systems into fully autonomous intelligence assets by synchronizing data across connected devices. The platform’s zero-signature design ensures complete operational security, allowing defense and rescue teams to conduct surveillance, reconnaissance, and engagement without GPS or active sensors.

Within Overwatch, the ATLAS Visibility Intelligence Engine enhances mission planning and reconnaissance through 2D and 3D visualization. Users can simulate line-of-sight coverage from any altitude, identify unseen or occluded areas, and optimize routes for surveillance or search and rescue. Operating entirely through software, ATLAS produces high-fidelity visibility data without mapping drones or additional power consumption, providing a lightweight, silent, and sensor-free alternative to lidar-based systems.

The SPARC AI SDK and open API framework extend Overwatch’s interoperability. Developers can embed SPARC AI’s intelligence into third-party systems such as PX4- and ArduPilot-powered drones, the world’s most widely used open-source flight platforms. The SDK provides REST APIs with bindings for Python, C++, and JavaScript and supports hardware including NVIDIA Jetson, Qualcomm Robotics RB5, and Raspberry Pi. Through these integrations, Overwatch serves as the command and intelligence layer of SPARC AI’s ecosystem, linking distributed drones, sensors, and edge devices into a coordinated autonomous network that operates entirely without GPS.

Market Opportunity

SPARC AI operates within the rapidly expanding defense, security, and commercial drone markets projected to exceed $100 billion over the next decade. The company’s software-defined approach addresses the global demand for autonomous systems capable of performing in denied, degraded, intermittent, and limited (DDIL) environments, positioning SPARC AI at the forefront of next-generation geolocation and targeting solutions.

Fortune Business Insights projects the global commercial drone market will reach approximately $65.25 billion by 2032, while Grand View Research estimates the combined drone hardware and services market will grow to $163.6 billion by 2030. With its per-device subscription model and integration across drones and robotic systems, SPARC AI is structured to capture recurring revenue from this accelerating adoption of GPS-denied intelligence technologies.

Leadership Team

Anoosh Manzoori, CEO, brings extensive experience as a technology entrepreneur, investor, and director, having founded, scaled, and exited multiple high-tech companies. He has taken five companies public, served on seven public company boards, and invested in innovations spanning cloud, fintech, biotech, IoT, defense, and AI.

Justin Hanka, Director, is an investment banking professional with 25 years of experience in mergers and acquisitions and capital markets. He has held executive roles at high-growth companies including iSelect.com.au and Helpmechoose, achieving multiple successful exits.

Anthony Haberfield, Director, is an international financial services executive with 30 years of experience across the Asia Pacific region, specializing in strategy, transformation, procurement, and emerging technology.

SPARC AI Inc. (OTCQB: SPAIF), closed Thursday's trading session at $1.6365, off by 7.5424%, on 129,461 volume. The average volume for the last 3 months is 301,680 and the stock's 52-week low/high is $0.0792/$2.9.

Recent News

• SPARC AI Inc. (CSE: SPAI) (OTCQB: SPAIF) - GPS Jamming Is the Hidden Aspect of War That Many People Aren't Aware Of
• TechMediaBreaks - SPARC AI Inc. (CSE: SPAI) (OTCQB: SPAIF) (Frankfurt: 5OV0) Appoints Ukraine-Based Referral Agent To Advance Defense Engagements
• Positioning for a GPS-Denied Future: SPARC AI Expands U.S. Defense Footprint with Proven Industry Leadership

ParaZero Technologies Ltd. (NASDAQ: PRZO)

The QualityStocks Daily Newsletter would like to spotlight ParaZero Technologies Ltd. (NASDAQ: PRZO).

ParaZero Technologies (NASDAQ: PRZO) reported full-year 2025 results highlighted by a 12.3% increase in revenue to approximately $1.05 million, driven by growing demand for its defense-focused solutions, including multiple purchase orders for its DefendAir counter-UAS platform from Israeli defense entities. The company strengthened its financial position with approximately $4.2 million in cash at year-end and an additional $7.5 million raised in 2026, while reducing net loss by 51% year over year and advancing global commercialization through regulatory approvals, strategic partnerships and expanded distribution across Europe and India.

To view the full press release, visit https://ibn.fm/JOSxV

ParaZero Technologies (NASDAQ: PRZO) announced a strategic partnership with XTEND (NASDAQ: JFB) to integrate its DefendAir net-launching system with XTEND’s Scorpio 1000 drone platform, enabling fully autonomous interception of hostile drones through AI-driven detection, tracking and kinetic net capture. The collaboration positions both companies to deliver advanced counter-UAS capabilities to global defense and security markets, combining high-speed maneuverability with safe interception technology designed to minimize collateral damage in complex operational environments.

To view the full press release, visit https://ibn.fm/3Tcsf

ParaZero Technologies Ltd. (NASDAQ: PRZO) is a defense aerospace company specializing in multi-layered Counter-Unmanned Aircraft System (“Counter-UAS”) technologies engineered to neutralize hostile drones in complex, contested, and urban environments. Founded by aviation and defense technology professionals, the company develops autonomous interception and precision-delivery systems that support military forces, homeland security agencies, and operators of strategic infrastructure. ParaZero’s mission is to provide reliable, practical, and scalable counter-drone capabilities for frontline and fixed-site defense scenarios where rapid, accurate, and low-collateral response is essential.

As drone threats evolve from low-cost commercial platforms to fast, low-signature systems operating in RF-denied conditions, ParaZero focuses on solutions that deliver actionable last-layer defense. Its technologies integrate with existing detection and command systems, allowing operators to respond effectively across military bases, sensitive facilities, border regions, and high-risk operational zones. The company’s defense portfolio continues to expand through field collaboration with Israeli defense authorities and international security organizations seeking capable interception systems.

Building on more than a decade of engineering and operational experience, ParaZero offers autonomous counter-drone and precision-delivery capabilities designed for modern defense requirements.

The company is headquartered in Kfar Saba, Israel.

DefendAir

DefendAir is ParaZero’s multi-layered Counter-UAS system designed to intercept hostile drones with high accuracy and minimal collateral damage. The platform employs patented net-interception technology and supports defense forces protecting bases, critical infrastructure, government facilities, and frontline units. Company-reported demonstrations conducted with Israeli defense and homeland security authorities have shown successful interception across a range of real-time scenarios involving fast, maneuverable, and RF-denied drones.

DefendAir is deployed through three complementary delivery mechanisms that enable flexible interception across dynamic battlefield and fixed-site environments:

• Interception Drone – The airborne configuration places a net-interception pod on an autonomous multirotor, enabling rapid engagement of hostile drones approaching from extended ranges or complex angles. This mobile layer offers adaptable response options where ground-based systems may have limited reach.
• Stationary Turret – The turret provides automated 360-degree perimeter coverage for fixed sites. Using optical detection and autonomous tracking, it identifies and intercepts approaching drones with a non-explosive, low-collateral method suitable for urban or sensitive environments.
• Hand-Held Net Launcher – The hand-held launcher offers infantry and security personnel a lightweight, tactical close-range interception tool. It enables unit-level drone neutralization in environments where jamming or spoofing is ineffective, providing a practical last-line defense option.

Together, these configurations provide flexible interception capabilities for a wide range of defense and security missions.

DropAir

DropAir is ParaZero’s high-accuracy aerial delivery solution engineered for autonomous or remotely controlled missions in complex and hostile environments. The system enables safe, precise delivery of sensitive payloads, including medical supplies, blood transfusions, tactical equipment, and humanitarian aid, without requiring the drone to land or expose ground personnel to risk. Its HALO-style late parachute deployment minimizes drift and lowers detectability, supporting both multirotor and fixed-wing UAVs.

DropAir has demonstrated operational effectiveness in collaboration with the Israeli Ministry of Defense and the Israel Defense Force Medical Corps, including a breakthrough field trial in which blood transfusions dropped from 200 meters were recovered fully intact and suitable for human use.

The system’s modular pod design secures a variety of payloads and is adaptable to a wide range of UAV platforms, with carrying capacities of 5, 10, or 20 kilograms depending on drone capability. Built for rapid deployment and all-weather performance, DropAir provides reliable resupply options for defense, disaster response, and remote operations where conventional logistics cannot safely reach.

Market Opportunity

ParaZero operates within rapidly expanding segments of the global unmanned systems and defense markets. According to Fortune Business Insights, the anti-drone (counter-UAS) market was valued at $2.4 billion in 2024 and is projected to grow from $3.1 billion in 2025 to $12.24 billion by 2032, reflecting a compound annual growth rate of 21.62%. This expansion is driven by the increasing use of drones in modern conflicts, the emergence of new threat types such as RF-denied and fiber-optic-guided drones, and the need to protect critical infrastructure, military bases, and sensitive facilities.

The precision airdrop category is also gaining traction as defense forces and emergency agencies seek secure, rapid, and unmanned delivery solutions for time-critical missions. ParaZero’s DropAir program has advanced into Phase II with the Israeli Defense Force Medical Corps, highlighting governmental adoption of autonomous delivery technologies for military and humanitarian use.

Leadership Team

Ariel Alon, Chief Executive Officer, is an experienced executive with a proven track record of leading high-performing business teams across unmanned aircraft systems, finance, high-tech, defense, and government sectors in Israel, the U.S., EMEA, and APAC. Prior to joining ParaZero, he served as Chief Sales Officer of Aerodrome Group and CEO of its subsidiary, Aerodrome LTD. His earlier roles include vice president of sales and general manager for Israel at Voyager Labs, Israeli country manager for Atos, and business development positions at companies including Elbit Systems and Rafael Advanced Defense Systems. Mr. Alon holds a B.A. in business administration and an M.B.A. in finance and marketing from the Ruppin Academic Center in Israel.

Regev Livne, Chief Financial Officer, previously served as CFO of Votiro, where he raised capital and supported the company’s expansion into North America and Asia. His earlier experience includes serving as CFO of SCR Engineers Ltd., along with finance roles at 3M Attenti and Dmatek Ltd. Mr. Livne began his career as a senior accountant at PwC Israel, auditing both public and private companies. He is a Certified Public Accountant in Israel and holds a master’s degree in finance and management and a B.A. in business administration and accounting from the Israeli College of Management.

Alon Yasovsky, Vice President of R&D, is an engineering leader with more than 20 years of experience across electro-optics, machine vision, embedded systems, and advanced technology development. He previously worked in Samsung Electronics Israel’s Open Innovation group and evaluated R&D investments for the Israeli Innovation Authority. Earlier in his career, he held engineering and leadership roles at SensoGenic, Kornit Digital, Intel, Apple, PrimeSense, and Elbit Systems. Mr. Yasovsky holds a B.Sc. in electrical and electronic engineering from Tel Aviv University and completed the U.S.–Israel Innovation Bridge Leadership Executives Program at the University of California, Irvine.

Paid Promotional Disclosure

This press release constitutes a paid promotional communication. The Company has engaged a third-party service provider to provide investor awareness and promotional services, including the dissemination of this press release, and has paid a fee for such services. The Company exercises editorial control over the content of this press release but does not control how, when, or to whom the information is distributed by such third party.

This press release is for informational purposes only and does not constitute an offer to sell or a solicitation of an offer to buy any securities of the Company. Investing in securities involves significant risks, and readers are encouraged to review the Company’s filings with the U.S. Securities and Exchange Commission available at www.sec.gov before making any investment decision.

ParaZero Technologies Ltd. (NASDAQ: PRZO), closed Thursday's trading session at $0.8244, off by 6.1048%, on 1,063,601 volume. The average volume for the last 3 months is 1,424,898 and the stock's 52-week low/high is $0.5255/$2.145.

Recent News

• ParaZero Technologies Ltd. (NASDAQ: PRZO) - TinyGemsBreaks - ParaZero Technologies Ltd. (NASDAQ: PRZO) Partners With XTEND (NASDAQ: JFB) To Advance Autonomous Counter-Drone Systems
• TechMediaBreaks - ParaZero Technologies Ltd. (NASDAQ: PRZO) Reports 2025 Results, Expands Defense Sector Momentum
• MissionIRNewsBreaks - ParaZero Technologies Ltd. (NASDAQ: PRZO) Closes $4M Registered Direct Offering Led By Aegis

Datavault AI Inc. (NASDAQ: DVLT)

The QualityStocks Daily Newsletter would like to spotlight Datavault AI Inc. (NASDAQ: DVLT).

Datavault AI (NASDAQ: DVLT) announced a strategic partnership with American Strategic Minerals Inc. to develop and monetize an Arizona-based resource extraction project through a $78.2 million digital tokenization initiative, with Datavault AI eligible to earn up to a 20% equity interest in ASMI upon achieving performance milestones. The initiative will begin with tokenizing antimony — a critical U.S. defense mineral — followed by gold, copper and silver, leveraging Datavault AI’s proprietary platforms to transform mineral assets into digital instruments while advancing domestic supply chain independence and unlocking value from a resource base exceeding $2.15 billion.

To view the full press release, visit https://ibn.fm/I5VED

Datavault AI Inc. (NASDAQ: DVLT) is a pioneering leader in immersive, wireless sound technology, providing cutting-edge audio solutions for intelligent devices and next-generation home entertainment systems. The company collaborates with top consumer electronics (CE) brands and manufacturers, including industry giants like Harman International (a division of Samsung), LG, Hisense, TCL, Bang & Olufsen, and Platin Audio. WiSA Technologies delivers exceptional wireless sound experiences for high-definition content, including movies, music, sports, gaming, and esports, thereby enhancing the overall consumer experience in home entertainment.

As a founding member of WiSA™ (the Wireless Speaker and Audio Association), WiSA Technologies plays a critical role in defining wireless audio interoperability standards, ensuring seamless integration across devices and platforms. The company actively works with leading consumer electronics companies, technology providers, retailers, and ecosystem partners to promote and market spatial audio technologies, underscoring its commitment to advancing the future of audio and making high-quality, immersive sound accessible to a broader audience.

Headquartered in Beaverton, Oregon, WiSA Technologies extends its global reach with sales teams strategically located in Taiwan, China, Japan, Korea, and California. This international presence allows the company to effectively serve a diverse customer base and maintain strong relationships with key partners worldwide. By continuously innovating and setting new benchmarks in wireless audio, WiSA Technologies is well-positioned to remain at the forefront of the evolving home entertainment landscape.

The WiSA Association

The WiSA® Association, a wholly owned subsidiary of WiSA Technologies, is dedicated to promoting and standardizing spatial audio solutions for home entertainment, ensuring that immersive audio experiences are accessible to everyone. In collaboration with leading consumer electronics companies, technology providers, retailers, and ecosystem partners, the association works to advance wireless audio technology across various devices, making high-quality sound an integral part of modern home entertainment systems. As a key player in the industry, WiSA LLC, also known as the Wireless Speaker and Audio Association, is instrumental in fostering the adoption and integration of cutting-edge audio technologies.

Recently, the WiSA Association significantly expanded its influence by executing licensing agreements with leading HDTV brands, covering 43% of the HDTV market that uses the Android operating system, the most widely used OS in the market. By focusing on Android-based HDTVs and collaborating with speaker manufacturers, WiSA is actively building an ecosystem of WiSA E-enabled speaker systems, mirroring the success of its earlier WiSA HT technology. This strategic initiative, combined with WiSA E’s compatibility with multiple HDTV SoC providers and support for spatial audio formats like Dolby Atmos FlexConnect, positions the association at the forefront of transforming home audio experiences, driving widespread adoption across the home entertainment landscape.

Market Opportunity

From an investment perspective, WiSA Technologies Inc. is strategically positioned to capitalize on the growing demand for wireless and immersive audio experiences as consumer preferences shift toward high-definition home entertainment systems. As streaming services, gaming, and smart home technologies continue to expand, the need for seamless, high-quality audio solutions is becoming increasingly critical. WiSA Technologies, with its innovative wireless sound technology and strong partnerships with leading consumer electronics brands, is well-placed to capture a significant share of this expanding market, particularly as more consumers seek to enhance their home entertainment experiences.

Moreover, the company’s focus on setting industry standards through the WiSA Association further solidifies its role as a key player in the evolving audio landscape. By driving the adoption of wireless audio interoperability standards, WiSA Technologies not only ensures broad compatibility across devices but also positions itself as a leader in the market, capable of influencing future trends and technologies. This proactive approach, combined with its established global presence and collaborations with top-tier brands, provides WiSA Technologies with a strong foundation for sustained growth, making it an attractive opportunity for investors looking to gain exposure to the burgeoning home entertainment and smart audio sectors.

Leadership Team

Brett Moyer is the Chief Executive Officer, President, and Chairman of WiSA Technologies, Inc., and a founding member of the company. He has served in these leadership roles since August 2010. Prior to this, Mr. Moyer was the president and CEO of Focus Enhancements, Inc., where he oversaw the development and marketing of proprietary video technology. He has a rich background in consumer electronics, having held key positions at Zenith Electronics Inc., including Vice President and General Manager of its Commercial Products Division. Mr. Moyer also serves on the board of directors of Alliant International University and has previously served on the boards of HotChalk, Inc., and NeoMagic Corporation. He holds a Bachelor of Arts in Economics from Beloit College and an MBA in Finance and Accounting from Thunderbird School of Global Management.

Gary Williams is the Chief Accounting Officer and Vice President of Finance at WiSA Technologies, Inc., roles he has held since September 2019 and the company’s founding in August 2010, respectively. He previously served as the company’s Chief Financial Officer and Secretary until 2019. Mr. Williams has extensive experience in finance, having served as CFO of Quantum3D, Inc., and in similar roles at Focus Enhancements Inc. and Videonics Inc. He began his career in public accounting with Coopers & Lybrand LLP. Mr. Williams is a certified public accountant (inactive) and holds a bachelor’s degree in business administration with an emphasis in accounting from San Diego State University.

Datavault AI Inc. (NASDAQ: DVLT), closed Thursday's trading session at $0.6091, off by 0.147541%, on 38,182,616 volume. The average volume for the last 3 months is 42,238,362 and the stock's 52-week low/high is $0.2512/$4.1.

Recent News

• Datavault AI Inc. (NASDAQ: DVLT) - Web3MediaBreaks - Datavault AI Inc. (NASDAQ: DVLT) Partners With American Strategic Minerals On $78.2 Million Tokenization Initiative
• MissionIRNewsBreaks - Datavault AI Inc. (NASDAQ: DVLT) Partners with Undefeated Heavyweight Prospect Moses Itauma Ahead of March 28 Bout
• Bolt, Nvidia Collaborate to Build Robotaxi Backbone in Europe

Canamera Energy Metals Corp. (CSE: EMET) (OTCQB: EMETF)

Disseminated on behalf of Canamera Energy Metals Corp., may include paid advertisements.

The QualityStocks Daily Newsletter would like to spotlight Canamera Energy Metals Corp. (CSE: EMET) (OTCQB: EMETF).

Disseminated on behalf of Canamera Energy Metals Corp. (CSE: EMET) (OTCQB: EMETF) and may include paid advertising.

• Canamera Energy Metals seeks to advance a portfolio of rare earth projects across Brazil, USA, and Canada.
• Specifically, the company is looking for rare earth elements (“REEs”), which are a group of 17 metals, useful for defense, high-performance electronics, industrial motors and automation, and several other applications and industries.
• The company recently made several announcement and updates, including announcing positive assay results from the first auger holes at the Turvolândia Rare Earth Project, and signing a letter of intent to potentially acquire an option for another REE project in Brazil.

Canamera Energy Metals (CSE: EMET) (OTCQB: EMETF) is a rare earth and critical metals exploration company that’s focused on developing a portfolio of district-scale mining opportunities across the Americas.

Canamera Energy Metals Corp. (CSE: EMET) (OTCQB: EMETF) is a rare earth and critical metals exploration company focused on developing a diversified portfolio of district-scale opportunities across the Americas. The company targets jurisdictions with supportive regulatory frameworks, strong geological signatures, and increasing strategic relevance as global supply chains seek alternatives to China’s rare earth dominance. Its assets span ionic clay systems in Brazil, carbonatite complexes in the United States and Canada, and underexplored terrains with meaningful geophysical and geochemical indicators.

Guided by a vision to support North American and allied rare earth supply chains, Canamera concentrates on high-conviction targets where early entry, scalable land positions, and efficient exploration can potentially unlock long-term value. The company’s mission is centered on generating discoveries aligned with the accelerating global demand for critical minerals essential to defense, advanced manufacturing, clean energy technology, and next-generation electronics. Through systematic data-driven exploration, Canamera aims to advance projects aligned with growing efforts to diversify rare earth supply across strategic jurisdictions.

The company is headquartered in Edmonton, Alberta.

Projects

Turvolândia – Minas Gerais, Brazil

Canamera holds an option to acquire up to a 100% ownership interest in the Turvolândia Rare Earth Ionic Clay Project, a 29,574-hectare land package located in Minas Gerais, Brazil’s top mining state and a region responsible for over 30% of national mineral output. The project sits within a prolific corridor of REE-rich alkaline rocks associated with the Poços de Caldas Complex, currently being advanced by multiple industry developers.

Turvolândia benefits from year-round road access, established infrastructure, and supportive local communities. The geological setting includes the São Vicente and Pouso Alegre complexes, where heavily weathered horizons host REE-enriched clays and minerals such as monazite and bastnäsite.

Early exploration confirms REE-bearing clays, with upcoming work focused on property-wide soil sampling and deeper drilling to test the primary ionic clay enrichment horizon and depth potential.

São Sepé – Rio Grande do Sul, Brazil

Canamera also holds an option to acquire up to a 100% interest in the São Sepé Project, which comprises 7,966 hectares in a province known for significant mining activity, including coal, gems, and titanium, and offers strong infrastructure and accessibility. The geology is dominated by an 11-km Rapakivi granite body and advanced-weathered granitoid rocks prospective for potential ionic clay REE mineralization.

While currently undrilled, initial soil sampling indicates the presence of REE enrichment potential. Three priority targets—Erica, Sara, and Maya—have been identified, with planned work including systematic soil sampling and drilling across defined zones. The project also covers a notable uranium-potassium-thorium anomaly, further supporting its rare earth potential.

Iron Hills – Colorado, USA

The Iron Hills Project consists of 85 unpatented lode claims totaling 1,756 acres, held at 100% ownership and located within the Iron Hills / Powderhorn carbonatite complex, one of the premier carbonatite-alkaline systems in the United States. Adjacent to Teck Resources’ Iron Hill deposit, host to one of the country’s largest rare earth oxide and titanium deposits, the project spans two non-contiguous claim blocks positioned along mapped intrusive contacts, felsite porphyry boundaries, and carbonatite dike projections.

Canamera staked these claims in 2025 as part of its U.S. expansion strategy supported by Rangefront Mining Services, and they are pending approval by the BLM.

Schryburt Lake – Ontario, Canada

Through a Joint Venture Option Agreement, Canamera may earn up to a 90% interest in the Schryburt Lake Project, a multi-center carbonatite-hosted REE–Nb system defined by four priority targets: Blue Jay, Goldfinch, Blackbird, and Starling.

These prospects exhibit coincident thorium radiometric highs, coherent magnetic bodies, surface anomalies, and historical trenching. Together, they outline the potential for a vertically extensive and multi-center REE–Nb system. Planned work includes a ~1,000-meter heli-supported scout drilling program following permitting and community consultation.

Garrow – Ontario, Canada

The Garrow Project covers 2,182 hectares located 43 km north-northeast of North Bay and is accessible year-round with strong local infrastructure. Canamera holds an option to acquire a 100% interest in the property.

Regional geochemical datasets include 26 samples above 500 ppm REE across Ontario, and three of these high-value anomalies occur within the Garrow Township area, making it a compelling target for early-stage exploration, including property-wide soil sampling and geophysics to delineate initial drill targets.

Market Opportunity

Rare earth elements play a central role in high-growth industries including electric vehicles, wind turbines, robotics, high-performance electronics, defense systems, and medical imaging, underpinning global trends in electrification, automation, and advanced manufacturing. Their application in permanent magnets, optics and lasers, catalysts, and nuclear and medical technologies positions them as foundational materials for both industrial innovation and national security.

Global demand for rare earth elements is projected to triple—from 59,000 tonnes in 2022 to 176,000 tonnes by 2035—driven by rapid EV adoption and wind-power expansion, with supply expected to lag by up to 30%, according to McKinsey & Company. The global REE market, valued at $3.95 billion in 2024, is forecast to reach $6.3 billion by 2030 at a compound annual growth rate of approximately 8.6%, according to Grand View Research, reflecting a sustained and widening supply-demand imbalance that supports new project development.

China currently controls approximately 60% of global rare earth mining and about 90% of processing capacity, reinforcing persistent price volatility and supply-chain concentration that have been highlighted by historical export restrictions, environmental crackdowns, and geopolitical disruptions. In response, North American governments have accelerated initiatives to strengthen domestic critical-minerals supply chains, including $1 billion in U.S. Department of Energy funding opportunities and Canada’s C$1.5 billion Critical Minerals Infrastructure Fund. Together, these structural shortages, policy tailwinds, and long-term electrification trends underscore the strategic relevance of Canamera’s diversified rare earth portfolio across Brazil, the United States, and Canada.

Leadership Team

Brad Brodeur, CEO & Director, brings more than 27 years of capital markets experience focused on venture-stage issuers, having led over $100 million in financings for junior and start-up companies following senior advisory roles at Raymond James, Canaccord Genuity, and Edward Jones.

Warren Robb, VP Exploration, brings over 35 years of global mineral exploration experience across North America, China, Africa, and South America, including senior roles with Nexus Gold, WPC Resources (now Bluestar Gold), Roxgold, TTM Resources, Majestic Gold, and Trivalence Mining.

Jelena Veljovic, CFO, brings public-company financial reporting and accounting expertise through her work with Treewalk Consulting in Vancouver, supported by prior experience in taxation and private-company accounting at Focus LLP in Calgary.

All technical and scientific information disclosed herein was reviewed and approved by Warren Robb, P.Geo (British Columbia), Vice-President, Exploration, of the Company and a “Qualified Person” as defined by National Instrument 43-101.

For a discussion of the Company’s QA/QC and data verification processes and procedures, please see its most recently filed technical report, a copy of which is available under Canamera’s profile at www.sedarplus.ca.

Canamera Energy Metals Corp. (OTCQB: EMETF), closed Thursday's trading session at $0.295, off by 4.8387%, on 98,311 volume. The average volume for the last 3 months is 133,540 and the stock's 52-week low/high is $0.279/$0.94.

Recent News

• Canamera Energy Metals Corp. (CSE: EMET) (OTCQB: EMETF) - Canamera Energy Metals Corp. (CSE: EMET) (OTCQB: EMETF) Provides Update on the Turvolândia Rare Earth Project as they Target Rare Earth Elements
• Canamera Energy Metals Corp. (CSE: EMET) (OTCQB: EMETF) Advances Rare Earth Portfolio with High-Grade Results in Colorado and Active Drilling in Brazil
• Canamera Energy Metals Corp. (CSE: EMET) (OTCQB: EMETF) Advances Strategic Rare Earth Positioning with Maiden Drill Program in Brazil